AC Immune Reports Positive Week-100 VacSYn Phase 2 Data
LAUSANNE, Switzerland — September 23, 2026 AC Immune SA reported positive safety and immunogenicity results through Week 100 from...
alpha-synuclein
Advertisement
CND Life Sciences Opens New Innovation Lab in Scottsdale
Scottsdale, Arizona, U.S., September 17, 2026 CND Life Sciences, Inc., a medical technology company focused on neurodiagnostic testing and...
Enable Biosciences Gains Brazil Approval for T1D Test
South San Francisco, California, U.S., September 17, 2026 Enable Biosciences, Inc. has announced that Brazil’s National Health Surveillance Agency...
AC Immune Receives FDA Fast Track Designation for ACI-7104 in Parkinson’s
LAUSANNE, Switzerland, August 11, 2026 AC Immune SA announced that the U.S. Food and Drug Administration (FDA) has granted...
Innogen Gains PIC/S GMP Certification for Efsubaglutide
Shanghai, China – August 4, 2026 Innogen Pharmaceuticals has announced that its Efsubaglutide alfa manufacturing facility in Suzhou has...
Advertisements
CND Life Sciences Secures Growth Funding for Syn-One Test
Scottsdale, Arizona & Boca Raton, Florida, August 4, 2026 CND Life Sciences has announced the successful completion of a...
Dyne Secures FDA IND Clearance for DYNE-302 in FSHD
Waltham, Massachusetts, July 28, 2026 Dyne Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has cleared...
Galmed Advances Brain-Targeted Aramchol for Parkinson’s
Ramat-Gan, Israel, July 28, 2026 Galmed Pharmaceuticals Ltd. has announced a significant advancement in the development of Aramchol orally...
Chiesi, Arbor Secure EU Orphan Status for ABO-101
PARMA, Italy & CAMBRIDGE, Mass., June 25, 2026 Chiesi Group and Arbor Biotechnologies have achieved a significant regulatory milestone...
Ionis Partners with Recordati to Expand Zilganersen Globally
CARLSBAD, Calif., June 25, 2026 Ionis Pharmaceuticals has entered into a landmark global licensing agreement with Recordati to accelerate...
Advertisement
